Paneth cells: Their role in innate immunity and inflammatory disease

Gut

Volumn 54, Issue 12, 2005, Pages 1802-1809

  Elphick, D A ^b   Mahida, Y R ^a,b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANGIOGENIN; ANTIINFECTIVE AGENT; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CRYPTDIN RELATED SEQUENCE PROTEIN; LYSOZYME; NUCLEOTIDE OLIGOMERIZATION DOMAIN PROTEIN 1; PHOSPHOLIPASE A2; PROTEIN DERIVATIVE; SECRETORY PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CELL FUNCTION; COLITIS; ENTERITIS; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTESTINE MUCOSA; MEDICAL RESEARCH; MICROFLORA; MICROORGANISM; MOLECULAR INTERACTION; NONHUMAN; PANETH CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SMALL INTESTINE; T LYMPHOCYTE;

HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NOD2 SIGNALING ADAPTOR PROTEIN; PANETH CELLS;

EID: 28144437207     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.068601     Document Type: Review

References (70)

1. Booth C, Potten CS. Gut instincts: thoughts on intestinal epithelial stem cells. J Clin Invest 2000;105:1493-9.
2. Justesen T, Nielsen OH, Jacobsen IE, et al. The normal cultivable microflora in upper jejunal fluid in healthy adults. Scand J Gastroenterol 1984;19:279-82.
3. Smith G, Gorbach S. Normal alimentary tract flora. In: Blaser M, Smith P, Ravidin J, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:53-69.
4. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000;343:338-44.
5. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004;25:570-7.
6. Campbell DJ, Kim CH, Butcher EC. Chemokines in the systemic organization of immunity. Immunol Rev 2003;195:58-71.
7. Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 2003;3:63-72.
8. Fernie-King B, Seilly DJ, Davies A, et al. Subversion of the innate immune response by micro-organisms. Ann Rheum Dis 2002;61(suppl 2):ii8-12.
9. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-3.
10. Philpott DJ, Girardin SE. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004;41:1099-108.
11. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
12. Rock FL, Hardiman G, Timans JC, et al. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998;95:588-93.
13. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-8.
14. Mahida YR, Johal S. NF-kappa B may determine whether epithelial cell-microbial interactions in the intestine are hostile or friendly. Clin Exp Immunol 2001;123:347-9.
15. Chamaillard M, Girardin SE, Viala J, et al. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003;5:581-92.
16. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappa B. J Biol Chem 2001;276:4812-18.
17. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
18. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
19. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20.
20. Paneth J. Uber Die Secernierenden Zellen das Dunndarm-Epithels. Archiv fur mikroskepisch anatomie 1888;31:113-92.
21. Bry L, Falk P, Huttner K, et al. Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci U S A 1994;91:10335-9.
22. Cheng H. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. IV. Paneth cells. Am J Anat 1974;141:521-35.
23. Ouellette AJ, Satchell DP, Hsieh MM, et al. Characterization of luminal Paneth cell alpha-defensins in mouse small intestine: Attenuated antimicrobial activities of peptides with truncated amino termini. J Biol Chem 2000;275:33969-73.
24. Lendrum A. The phloxine-tartrazine method as a general histological stain and for the demonstration of inclusion bodies. J Pathol Bacteriol 1947;59:399-404.
25. Erlandsen SL, Parsons JA, Taylor TD. Ultrastructural immunocytochemical localization of lysozyme in the Paneth cells of man. J Histochem Cytochem 1974;22:401-13.
26. Cunliffe RN, Rose FR, Keyte J, et al. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 2001;48:176-85.
27. Nevalainen TJ, Gronroos JM, Kallajoki M. Expression of group II phospholipase A2 in the human gastrointestinal tract. Lob Invest 1995;72:201-8.
28. Kamal M, Wakelin D, Ouellette AJ, et al. Mucosal T cells regulate Paneth and intermediate cell numbers in the small intestine of T. spiralis-infected mice. Clin Exp Immunol 2001;126:117-25.
29. Ayabe T, Satchell DP, Wilson CL, et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000;1:113-18.
30. Tanabe H, Ayabe T, Bainbridge B, et al. Mouse paneth cell secretory responses to cell surface glycolipids of virulent and attenuated pathogenic bacteria. Infect Immun 2005;73:2312-20.
31. Rumio C, Besusso D, Palazzo M, et al. Degranulation of paneth cells via toll-like receptor 9. Am J Pathol 2004;165:373-81.
32. Lala S, Ogura Y, Osborne C, et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003;125:47-57.
33. Ogura Y, Lala S, Xin W, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003;52:1591-7.
34. Hornef MW, Putsep K, Karlsson J, et al. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat Immunol 2004;5:836-43.
35. Hooper LV, Stappenbeck TS, Hong CV, et al. Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-73.
36. Klockars M, Reitamo S. Tissue distribution of lysozyme in man. J Histochem Cytochem 1975;23:932-40.
37. Coutinho HB, Carmona da Mota H, Coutinho VB, et al. Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol 1998;51:512-14.
38. Harwig SSL, Tan L, Qu XD, et al. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest 1995;95:603-10.
39. Qu XD, Lloyd KC, Walsh JH, et al. Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun 1996;64:5161-5.
40. Ouellette AJ, Bevins CL. Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 2001;7:43-50.
41. Cunliffe RN, Mahida YR. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J Leukoc Biol 2004;75:49-58.
42. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286:113-7.
43. Lencer WI, Cheung G, Strohmeier GR, et al. Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc Natl Acad Sci U S A 1997;94:8585-9.
44. Lin PW, Simon PO Jr, Gewirtz AT, et al. Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J Biol Chem 2004;279:19902-7.
45. Ouellette AJ, Greco RM, James M, et al. Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol 1989;108:1687-95.
46. Ouellette AJ, Hsieh MM, Nosek MT, et al. Mouse Paneth cell defensins: Primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun 1994;62:5040-7.
47. Salzman NH, Chou MM, De Jong H, et al. Enteric Salmonella infection inhibits paneth cell antimicrobial peptide expression. Infect Immun 2003;71:1109-15.
48. Jones DE, Bevins CL Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992;267:23216-25.
49. Porter EM, Poles MA, Lee JS, et al. Isolation of human intestinal defensins from ileal neobladder urine. FEBS Letters 1998;434:272-6.
50. Porter EM, Van Dam E, Valore EV, et al. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 1997;65:2396-401.
51. Ghosh D, Porter E, Shen B, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002;3:583-90.
52. Salzman NH, Ghosh D, Huttner KM, et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003;422:522-6.
53. Bohe M, Borgstrom A, Lindstrom C, et al. Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol 1986;39:786-93.
54. Molmenti EP, Perlmutter DH, Rubin DC. Cell-specific expression of alpha1-antitrypsin in human intestinal epithelium. J Clin Invest 1993;92:2022-34.
55. Kelly P, Feakins R, Domizio P, et al. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol 2004;135:303-9.
56. Knight PA, Pemberton AD, Robertson KA, et al. Expression profiling reveals novel innate and inflammatory responses in the jejunal epithelial compartment during infection with Trichinella spiralis. Infect Immun 2004;72:6076-86.
57. Wong WM, Stamp GWH, Elia G, et al. Proliferative populations in intestinal metaplasia: Evidence of deregulation in Paneth and goblet cells, but not endocrine cells. J Pathol 2000;190:107-13.
58. Smith VC, Genta RM. Role of Helicobacter pylori gastritis in gastric atrophy, intestinal metaplasia, and gastric neoplasia. Microsc Res Tech 2000;48:313-20.
59. Sandow MJ, Whitehead R. The Paneth cell. Gut 1979;20:420-31.
60. Watanabe H. Experimentally induced intestinal metaplasia in Wistar rats by X-ray irradiation. Gastroenterology 1978;75:796-9.
61. Klockars M, Reitamo S, Reitamo JJ, et al. Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease. Gut 1977;18:377-81.
62. Haapamaki MM, Gronroos JM, Nurmi H, et al. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut 1997;40:95-101.
63. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869-72.
64. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003;278:5509-12.
65. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
66. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
67. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
68. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-4.
69. Pauleau AL, Murray PJ. Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol Cell Biol 2003;23:7531-9.
70. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53:1658-64.